Royals left-hander Cole Ragans undergoes UCL surgery, expected to miss 10 to 12 months

Kansas City’s starting rotation will be without left-hander Cole Ragans for a significant stretch after the team underwent surgery on his throwing-elbow ulnar collateral ligament, according to reports from ’s Anne Rogers and subsequent coverage. The surgery resolves a timeline that had been trending toward an elbow procedure for more than a week, but it also confirms the seriousness of the injury and forces the Royals to shift how they manage innings and leverage within their rotation depth.

The latest reporting says the Royals expect Ragans to miss roughly 10 to 12 months following the operation. That estimate matters because UCL procedures can vary in both approach and recovery duration, and the specific timetable influences how aggressively Kansas City can plan for his return as the calendar moves toward late-summer and postseason contention windows.

It was first reported that Ragans would need surgery on his left elbow, though at that stage the nature of the repair was unclear. With the procedure now confirmed, multiple outlets framed the expected 10 to 12 month absence as a sign the Royals may be dealing with a recovery course shorter than what is often associated with a traditional Tommy John reconstruction. Any link between recovery length and the exact method should be treated as informed interpretation rather than a formal medical statement, but it helps explain why the Royals’ expectations have become more concrete.

Ragans has been a key part of Kansas City’s left-handed leverage in the rotation, and losing a starter for the better part of a season typically affects more than one spot in the batting order. When a front-line arm goes out, teams usually have to shuffle roles among remaining starters, expand bullpen usage earlier in games, and decide whether to keep certain relievers in longer stints to protect late-inning matchups.

The baseball calendar also means the Royals will need to cover the innings gap during periods when teams commonly rely on their most established pitching plans. If Ragans is indeed on a 10 to 12 month timeline, his return would most likely come after a full offseason has passed, turning 2026’s final stretch into a pivot point for organizational evaluation rather than a direct continuation of the season’s original plan.

For Ragans, the immediate next steps are typical of the post-surgical process: a progression built around rebuilding elbow health, throwing mechanics, and arm strength, with pitch timing controlled by medical clearance. For the Royals, the near-term focus will be on stabilizing the rotation while monitoring how other starters and long-relief options respond to increased workload.

What to watch next is how Kansas City structures the rotation in Ragans’ absence, including whether it leans more heavily on internal depth or accelerates opportunities for lesser-used starters and bullpen arms. Just as important, any update on the specific medical approach and the formal rehab milestones will determine how confidently the Royals can project a return date later in the year.